Skip to content

Clinical Observation for Bu-Shen Huo-Xue Decoction in the Treatment of Lumbar Degenerative Diseases

Clinical Observation for Bu-Shen Huo-Xue Decoction in the Treatment of Discogenic Low Back Pain

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002785
Enrollment
Unknown
Registered
2019-11-28
Start date
2019-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discogenic Low Back Pain

Interventions

Sponsors

Wangjing Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Conforms to Western medicine diagnosis and TCM syndrome differentiation standards; 2. Aged between 20-60 years old; 3. Those who volunteer to conduct clinical trials and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. X-ray or CT imaging examination showed lumbar spondylolysis, lumbar spondylolisthesis, disc herniation, lumbar spinal stenosis and other abnormalities; 2. physical examination showed obvious symptoms of nerve root compression; 3. There are organic lesions in the spine (such as fractures, tuberculosis, tumors, strong spinal inflammation, etc.); 4. Concomitant patients with severe primary diseases such as internal medicine and those with bleeding tendency; 5. Women who are pregnant, pregnant or breastfeeding; 6. Patients who are participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
Oswestry disability index;Visual analogue scales;

Secondary

MeasureTime frame
Waist tenderness;Safety indicator;Lumbar motion;Muscle tension measurement;

Countries

China

Contacts

Public ContactZhan Jiawen
zhanjiawen12@126.com+86 13011862310

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026